EquityZen Growth Technology Fund LLC - Series 231
Raised
$705K
Investors
5
Min Invest
$10,000
AltStreet Analysis
·Generated from EDGAR primary sources
EquityZen Growth Technology Fund LLC - Series 231 is a Delaware pooled investment fund vehicle filed by EquityZen Advisors on 2018-04-04, raising $705K from 5 investors under Rule 506(b) and 3(c)(1) exemptions. The offering has a $10K minimum investment and is part of the EquityZen platform, which operates nearly 1,900 related entities focused on pre-IPO secondary market access.
This pre-IPO fund uses the standard 506(b)/3(c)(1) exemption pattern typical of private secondary market vehicles, with a $10K minimum positioning it for accredited retail rather than institutional investors. The capital raised ($705K from 5 investors, averaging $141K per commitment) aligns with EquityZen's series-vehicle model for pooling investor capital into individual pre-IPO company positions.
Data Flags
EDGAR Filing Data
Form D — Primary Source
View on SEC.govRelated Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
EquityZen Advisors LLC
Executive Officer, Director · New York, NY
Richard Thoms
Executive Officer · Salt Lake City, UT
Assure Fund Management II LLC
Director · Salt Lake City, UT
Shriram Bhashyam
Executive Officer, Director · New York, NY
Is this your offering?
Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.
